198 Participants Needed

Sit-stand Desk for Diabetes Prevention

JK
RK
Overseen By
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether using a sit-stand desk at work can help individuals at risk for type 2 diabetes improve their health. The researchers aim to determine if standing for part of the workday can boost insulin sensitivity and enhance heart health without altering exercise habits. Participants will be divided into three groups: one with no desk changes, one standing for at least 2 hours a day, and another for at least 3 hours. Suitable candidates include those with a sedentary office job, a BMI of 25 or higher, and a risk for diabetes due to prediabetes or other factors. As an unphased trial, this study provides a unique opportunity to explore innovative lifestyle changes that could enhance health.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are on diabetes medications or insulin, you are excluded from participating.

What prior data suggests that this sit-stand desk intervention is safe for diabetes prevention?

Research has shown that sit-stand desks are generally safe and easy to use. In a previous study, participants reported no major negative effects. Instead, they experienced benefits such as improved physical health and enhanced mental well-being. Another study found that using sit-stand desks reduced sitting time, which is linked to a lower risk of developing Type 2 Diabetes.

No major safety concerns or harmful side effects were reported with sit-stand desks. Most changes observed were positive, including improved focus at work and reduced fatigue. These desks are designed to help reduce sitting time, potentially improving health without requiring changes to exercise or diet habits.12345

Why are researchers excited about this trial?

Researchers are excited about exploring sit-stand desks as a method for diabetes prevention because these desks offer a unique approach compared to traditional lifestyle interventions like medication or intensive exercise programs. Unlike typical treatments that often require significant lifestyle changes or medication adherence, sit-stand desks encourage increased physical activity in a simple and accessible way by allowing users to switch between sitting and standing throughout the workday. This method not only integrates seamlessly into a person's daily routine but also aims to reduce sedentary behavior, a known risk factor for diabetes, potentially leading to improved metabolic health with minimal disruption to daily life.

What evidence suggests that the sit-stand desk intervention is effective for diabetes prevention?

Research has shown that sit-stand desks can improve health by reducing sitting time. In one study, office workers who typically sit for long periods used a sit-stand desk for six months, resulting in a 23% improvement in insulin resistance. Insulin resistance is a risk factor for type 2 diabetes. Long-term use of these desks has also been linked to better blood vessel health and reduced signs of heart disease. Another study found that sit-stand desks helped decrease sitting time at work, which is important because less sitting is associated with better health. This trial will evaluate the effectiveness of sit-stand desks in preventing diabetes. Participants in the 2-Hour Group and 3-Hour Group will use sit-stand desks for at least 2 or 3 hours each workday, respectively, while the Control group will not receive a sit-stand desk. These findings suggest that using a sit-stand desk might help prevent diabetes, especially for those who stand more during the day.34678

Are You a Good Fit for This Trial?

This trial is for sedentary workers at the Medical College of Wisconsin with a BMI over 25, who are at risk for type 2 diabetes due to factors like family history or prediabetes. Participants should not be currently using a standing desk, have no major cardiovascular diseases, musculoskeletal disorders, uncontrolled hypertension, or other specific health conditions.

Inclusion Criteria

I have a parent, sibling, or child with diabetes.
You are too heavy for your height.
Considered to be at risk for diabetes.
See 7 more

Exclusion Criteria

You have used tobacco in the last 12 months.
I have fainted or felt dizzy when standing up.
I have been diagnosed with heart failure or cardiomyopathy.
See 16 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Objective assessments of activity levels and sedentary times using an accelerometer for 7 full days

1 week
1 visit (in-person)

Treatment

Participants are randomized into one of three groups: sit-stand desk intervention targeting 2 hours standing per day, sit-stand desk intervention targeting 3 hours standing per day, or control arm over 6 months

6 months
3 visits (in-person) at baseline, 3 months, and 6 months

Follow-up

Participants are monitored for changes in insulin sensitivity, metabolic and vascular health

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Sit-stand desk intervention
Trial Overview The study tests if sit-stand desks can improve insulin sensitivity and metabolic health in office workers at risk for diabetes. It randomly assigns participants to use the desk either 2 or 3 hours daily or to a control group without this intervention over six months while monitoring their activity levels.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: ControlExperimental Treatment1 Intervention
Group II: 2-Hour GroupActive Control1 Intervention
Group III: 3-Hour GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

Published Research Related to This Trial

The ACTIVE OFFICE trial is a 1-year randomized controlled study involving 18 healthy office workers in Austria, designed to evaluate the impact of two-desk sit-to-stand workstations on reducing sitting time and improving physical and cognitive performance.
If successful, the intervention could significantly reduce health risks associated with prolonged sitting in office environments, highlighting its potential for widespread implementation in workplaces.
Effect of a novel two-desk sit-to-stand workplace (ACTIVE OFFICE) on sitting time, performance and physiological parameters: protocol for a randomized control trial.Schwartz, B., Kapellusch, JM., Schrempf, A., et al.[2018]
This study aims to assess whether providing office workers with education and adjustable sit-stand workstations can effectively reduce sedentary behavior, which is linked to poor metabolic health.
The trial will involve a randomized control design with three groups, measuring the primary outcome of average daily sedentary time using accelerometers, to determine the effectiveness of the interventions over a period from March to December 2013.
Evaluation of ergonomic and education interventions to reduce occupational sitting in office-based university workers: study protocol for a randomized controlled trial.Radas, A., Mackey, M., Leaver, A., et al.[2022]
Project STAND is a randomized controlled trial aimed at reducing sedentary behavior in younger adults (ages 18-40) at high risk for Type 2 Diabetes Mellitus (T2DM), involving 178 participants split between intervention and control groups.
The primary outcome of the study is to measure the reduction in sedentary behavior over 12 months using accelerometers, with secondary outcomes including various health metrics like physical activity levels, glucose tolerance, and body weight, which will help inform future interventions for this high-risk population.
Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: project stand (Sedentary Time ANd diabetes).Wilmot, EG., Davies, MJ., Edwardson, CL., et al.[2022]

Citations

Acute Effect of Height-Adjustable Workstations on Blood ...Weight reduction and increased physical activity are effective strategies for preventing or delaying the onset of type 2 diabetes mellitus, and reducing ...
Sit-stand Desk for Diabetes PreventionIn our pilot study of 15 subjects with sedentary office jobs, 6 months of sit-stand desk use resulted in a 23% improvement in insulin resistance, most ...
The Impact of Standing Desks on Cardiometabolic and ...Long-term use of a sit-stand workstation reduced daily sedentary time and led to improvements in lower extremity vascular function and markers of ...
a Qualitative Exploration of Sit-Stand Desk Use in ...Perceived benefits reported included improved physical health and mental well-being, and work-related benefits such as increased concentration, ...
The effectiveness of sit-stand workstations for changing office ...This study shows that introducing sit-stand workstations in the office can reduce desk-based workers' sitting time at work in the short term.
Effects of a Workplace Sit–Stand Desk Intervention on ...This study assessed the relationship between the introduction of a sit–stand desk and its ability to reduce the negative effects of sitting too long.
The effectiveness of a 6-month intervention with sit-stand ...Higher SB in the office has been related to lower job satisfaction and greater fatigue, and previous findings suggest that less SB was associated with positive ...
A systematic review of standing and treadmill desks in the ...Treadmill desks led to the greatest improvement in physiological outcomes including postprandial glucose, HDL cholesterol, and anthropometrics, while standing ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security